Insider trades
Frank Yocca, Chief Officer of BioXcel Therapeutics BTAIQ, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $7,461. The latest trade was on 06/15.
Frank Yocca
Chief Scientific Officer
- Company
- BioXcel Therapeutics BTAIQ
- First filing
- 23/01/24
- Trades
- 67 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$7,461
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 05/20 | 05/22 | 6,845 sh | $1.09 | $7,461.05 | −20.7% |
BTAIQ | Open-market sale10b5-1 plan | 24/12/16 | 24/12/17 | 430 sh2 trades | $0.35avg. | $152.55 | −1.5% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/10/03 | 24/10/03 | 7,175 sh | $0.55 | $3,946.25 | −20.2% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/09/16 | 24/09/17 | 355 sh | $0.69 | $244.95 | −2.4% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/06/17 | 24/06/18 | 372 sh | $1.28 | $476.16 | −2.7% |
BioXcel TherapeuticsBTAIQ | Open-market sale10b5-1 plan | 24/04/04 | 24/04/08 | 1,067 sh | $2.64 | $2,816.88 | −7.7% |
BioXcel TherapeuticsBTAIQ | Open-market sale | 23/03/15 | 23/03/16 | 985 sh | $19.69 | $19,394.65 | −9.4% |
BioXcel TherapeuticsBTAIQ | Open-market sale | 23/01/20 | 23/01/24 | 50,000 sh | $30.00 | $1,500,000 | −85.6% |